New service offering!
Portrait Flex takes circulating tumor cell (CTC) analysis to the next level.
cellbxhealth.comCrawled Nov 17, 2026
Portrait Flex takes circulating tumor cell (CTC) analysis to the next level.
ANGLE’s Portrait PD-L1 testing solution is a novel approach for evaluating the expression of PD-L1 on circulating tumour cells (CTCs).
Parsortix PC1 system: FDA-cleared, non-invasive liquid biopsy system captures & harvests intact CTCs for cancer research & clinical trials.
CelLBxHealth announces the shipment of its first batch of Portrait+ CTC Staining Kits to customers.
CelLBxHealth - CTC harvest and analysis using the Parsortix platform, CellKeep slide and staining kit for precision oncology
Translational Research: CelLBxHealth helps to identify biomarkers, aiding personalised cancer therapies for optimal patient outcomes
Molecular profiling of CTC-DNA, from CTCs enriched by Parsortix technology, alongside ctDNA from the same blood sample has the potential to revolutionize cancer treatment.
Complementary insights from a single blood sample utilising the Parsortix system.
The page lists CelLBxHealth’s two poster presentations at EBCC, displayed at poster boards PB-117 and PB-123.
Circulating tumor cells (CTCs) harvested using the Parsortix system, reveal a gene expression profile associated with development and progression of brain metastasis in melanoma.
Research demonstrates the potential of the Parsortix system to support powerful characterisation of CTCs in head and neck cancer.
Parsortix system outperforms current laboratory standard for disseminated tumour cell (DTC) harvest.
Anne-Sophie Pailhes-Jimenez discusses how Parsortix technology enhances liquid biopsy analysis by enriching circulating tumor cells (CTCs).
CelLBxHealth will showcase Parsortix technology and new Portrait+ CTC staining kits at booth 3054 in San Diego.
CelLBxHealth invites visitors to booth 77 to discuss CTC enrichment and analysis for cancer research.
We have two new exciting posters at the Biomarkers in Tissue and Blood poster session at EACR 2024 Congress 11:00 to 8:15PM.
Leaders in liquid biopsy dedicated to improving cancer patient care. Discover vacancies, explore clinical research jobs & learn about the team
CelLBxHealth seeks a Research and Development Group Lead to oversee molecular and imaging assay development in Guildford.
The Scientist I role involves designing, optimizing, and validating molecular assays for research and diagnostic products.
CelLBxHealth’s investor relations page names trusted advisors, including auditors, bankers, lawyers, and brokers.
Dr. Jan Groen has expertise in product development, including development & commercialisation of CE marked & FDA cleared diagnostic products
Dr. Daniel Danila brings expertise in development & adoption of CTCs as predictive biomarkers to help clinicians select treatments
Dr. James M. Reuben brings to the SAB knowledge and understanding of CTCs, breast cancer and wide network of contacts in the field.
CelLBxHealth describes its team of liquid biopsy experts and their focus on improving patient care through management, advisory boards, and directors.
Consultant Urological Surgeon Prof. Greg L Shaw brings to the SAB expertise in prostate cancer diagnostics and treatment.
Liquid biopsies, CTC detection & analysis experts. FDA-cleared Parsortix captures intact CTCs, improving cancer care with non-invasive biopsy
CelLBxHealth plc: Explore QCA compliance, stakeholder engagement, and responsible growth for investor confidence.
The page promotes CelLBxHealth’s attendance at liquid biopsy and precision oncology conferences, highlighting the Parsortix PC1 system.
CelLBxHealth: Download, view & verify ISO 13485 & 15189 compliance certificates for medical device & laboratory standards.
CelLBxHealth outlines its market landscape and the role of Parsortix in advancing personalized medicine.
CelLBxHealth presents its liquid biopsy solutions and their application in improving patient care.
CelLBxHealth - Revolutionising Cancer Diagnosis & Treatment
Revolutionising cancer care through the power of liquid biopsy: Discover FDA-cleared Parsortix PC1 system, global laboratory services
The page explains CelLBxHealth’s data handling practices, cookie management, and privacy policy preferences.
Navigate CelLBxHealth website use: Legal terms & conditions explained. Covers copyright, user restrictions, warranties, liability, privacy & more